Marshall Wace North America’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-268	Closed	-$51K	–	1585
2019 Q4	$51K	Buy	+268	New	+$51K	﹤0.01%	1151
2019 Q2	–	Sell	-892	Closed	-$179K	–	1589
2019 Q1	$179K	Buy	+892	New	+$179K	﹤0.01%	1010